Disc Medicine Inc
Research Disc Medicine Inc (IRON) on Bullrun: market cap USD 3.16B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIRON
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 3.16B
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 59.53M
- Free cash flow-USD 44.20M
Valuation Snapshot
latest market cap is USD 3.16B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 212.18M | -USD 181.33M | n/a | -6.01 | USD 91.15M | USD 29.16M | USD 739.83M |
| FY2024 | USD 0 | -USD 109.36M | -USD 94.43M | n/a | -3.96 | USD 192.43M | USD 28.32M | USD 443.59M |
| FY2023 | n/a | -USD 76.43M | -USD 73.55M | n/a | -3.42 | USD 360.38M | USD 0 | USD 345.12M |
| FY2022 | n/a | -USD 46.83M | -USD 42.40M | n/a | -45.05 | USD 194.61M | USD 2.91M | USD 176.60M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 3.16B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.01B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.89B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.39B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 336.60M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 377.21M | n/a | n/a | n/a |
About Disc Medicine Inc
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Disc Medicine Inc's market cap?
Disc Medicine Inc's market capitalization is USD 3.16B.
What does Disc Medicine Inc do?
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis.